Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 26 for Chronic lymphoid leukemia

Edit search filters
  1. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  2. A Study To Evaluate Acalabrutinib With Or Without Obinutuzumab To Treat Early-Stage Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Combination Therapy Of Acalabrutinib, Venetoclax And Durvalumab To Treat Richter Transformation

    Rochester, MN

  4. Cholecalciferol In Improving Survival In Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study To Investigate The Safety And Tolerability Of REGN1979 In Patients With CD20+ B-Cell Malignancies

    Rochester, MN

  6. A Study Of CG-806 In Patients With Relapsed Or Refractory CLL/SLL Or Non-Hodgkin's Lymphomas

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Study Of Bcl-2 Inhibitor BGB-11417 In Participants With Mature B-Cell Malignancies

    Rochester, MN

  8. ACP-196 In Combination With Pembrolizumab, For Treatment Of Hematologic Malignancies

    Jacksonville, FL, Rochester, MN

  9. A Study Of APG-3288 In Relapsed/Refractory Blood Cancers

    Jacksonville, FL

  10. A Study To Evaluate Exercise For Cancer Patients At Risk Of Falling

    Rochester, MN

.

Mayo Clinic Footer